Takeda Pharmaceutical Co Ltd 20-F for FY2026
Takeda Pharmaceutical Co Ltd (TAK)
20-F
2026-06-17
For: 2026-03-31
View Original
Added on
June 17, 2026
About this 20-F
Takeda Pharmaceutical Co Ltd filed this 20-F on June 17, 2026, covering the fiscal year ended March 31, 2026 (FY2026).
Headline figures
Fiscal year ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 4.51T JPY
- down 1.7% from 4.58T JPY a year earlier
- Net loss
- 152.39B JPY
- compared with net income of 107.93B JPY a year earlier
- Diluted EPS
- -96.75 JPY
- compared with 67.23 JPY a year earlier